Related Experiment Video
Updated: May 29, 2026
08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Eclampsia-scenario in a hospital--a ten years study
A Pal1, R Bhattacharyya, S Adhikari
1Department of Gynaecology & Obstetrics, Burdwan Medical College, Burdwan.
Bangladesh Medical Research Council Bulletin
|September 1, 2011
Summary
This study analyzed 5991 eclamptic mothers, finding that magnesium sulfate and planned delivery reduced maternal and infant mortality. Improved management strategies led to better outcomes in later years.
Area of Science:
- Obstetrics and Gynecology
- Perinatology
- Public Health
Background:
- Eclampsia remains a significant cause of maternal and perinatal mortality globally.
- Understanding the outcomes associated with different anticonvulsant medications is crucial for improving patient management.
Purpose of the Study:
- To analyze maternal and perinatal outcomes in eclamptic mothers treated with various anticonvulsant medications.
- To evaluate the effectiveness of different management strategies over a ten-year period.
Main Methods:
- A cross-sectional, record-based study of 5991 eclamptic mothers admitted between 1999 and 2008.
- Management followed standard regimens including magnesium sulfate; outcomes like case fatality rate, induction-delivery time, birth weight, and perinatal mortality were recorded.
Main Results:
- Eclampsia incidence was higher in mothers <20 years, from rural areas, primigravida, and unbooked mothers.
- Overall case fatality rate was 6.05%, with eclampsia contributing significantly to maternal deaths.
- Low birth weight and perinatal mortality rates showed a decrease in the last four years of the study.
Conclusions:
- Proper socio-demographic assessment, planned delivery, and effective seizure control with magnesium sulfate are key to reducing maternal and perinatal morbidity and mortality.
- Intensive intranatal monitoring further contributes to improved outcomes in eclamptic pregnancies.
